Variations in chondrogenesis of human bone marrow-derived mesenchymal stem cells in fibrin/alginate blended hydrogels
Source abstract
Abstract
Fibrin and alginate hydrogels have been widely used to support chondrogenesis of bone marrow-derived mesenchymal stem cells (BM-MSCs) for articular cartilage and fibrocartilage tissue engineering, with each material offering distinct advantages and disadvantages. Attempting to produce a gel scaffold exhibiting beneficial characteristics of both materials, we fabricated fibrin/alginate blended hydrogels at various blend ratios and evaluated the gel morphology, mechanical properties and their support for BM-MSC chondrogenesis. Results show that when the fibrin/alginate ratio decreased, the fibrin architecture transitioned from uniform to interconnected fibrous and finally to disconnected islands against an alginate background, with opposing trends in the alginate architecture. Fibrin maintained gel extensibility and promoted cell proliferation, while alginate improved the gel biostability and better supported glycosaminoglycan and collagen II production and chondrogenic gene expression. Blended gels had physical and biological characteristics intermediate between fibrin and alginate. Of the blends examined, FA 40:8 (40 mg ml(-1) fibrinogen blended with 8 mg ml(-1) alginate) was found to be the most appropriate group for future studies on tension-driven BM-MSC fibrochondrogenesis. As BM-MSC differentiation appeared to vary between fibrin and alginate regions of blended scaffolds, this study also highlighted the potential to develop spatially heterogeneous tissues through manipulating the heterogeneity of scaffold composition.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesenchymal stem cell research · Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (56)
Show source-provided references
1. Tissue engineering meniscus: cells and matrix10.1016/S0030-5898(05)70160-7 ↗
2. The menisci of the knee joint. Anatomical and functional characteristics and a rationale for clinical treatment10.1046/j.1469-7580.1998.19320161.x ↗
3. Spatial organization of types I and II collagen in the canine meniscus10.1016/j.orthres.2004.06.016 ↗
4. Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study10.1007/s00418-005-0005-0 ↗
5. The concentration, gene expression, and spatial distribution of aggrecan in canine articular cartilage, meniscus, and anterior and posterior cruciate ligaments: a new molecular distinction between hyaline cartilage and fibrocartilage in the knee joint10.1080/03008200590954113 ↗
6. Regional variations in the distribution and colocalization of extracellular matrix proteins in the juvenile bovine meniscus10.1111/j.1469-7580.2012.01523.x ↗
7. Hellio Le Graverand MP, Ou Y, Schield-Yee T, Barclay L, Hart D, Natsume T, et al. The cells of the rabbit meniscus: their arrangement, interrelationship, morphological variations and cytoarchitecture. J Anat 2001;198:525–35.10.1046/j.1469-7580.2000.19850525.x ↗
8. Discrimination of meniscal cell phenotypes using gene expression profiles10.22203/eCM.v023a15 ↗
9. Meniscal tears, repairs and replacement: their relevance to osteoarthritis of the knee10.1136/bjsm.2010.081257 ↗
10. Arthroscopic evaluation of meniscal repairs. Factors that effect healing10.1177/036354659402200611 ↗
11. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model10.1242/jcs.113.7.1161 ↗
12. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–7.10.1126/science.284.5411.143 ↗
13. Tensile loading modulates bone marrow stromal cell differentiation and the development of engineered fibrocartilage constructs10.1089/ten.tea.2009.0561 ↗
14. Lee CH, Sun JY, Mao JJ. Fibrochondrocytes as potential therapeutic cells from human mesenchymal cells. TERMIS-NA 2010 Annual Conference and Exposition 2010:378.
15. Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions10.1002/jbm.b.30053 ↗
16. The influence of an aligned nanofibrous topography on human mesenchymal stem cell fibrochondrogenesis10.1016/j.biomaterials.2010.04.036 ↗
17. Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid10.1016/j.biomaterials.2011.08.073 ↗
18. Potential of 3-D tissue constructs engineered from bovine chondrocytes/silk fibroin-chitosan for in vitro cartilage tissue engineering10.1016/j.biomaterials.2011.04.061 ↗
19. Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: an experimental study in the goat10.1016/S0142-9612(97)00190-7 ↗
20. Chondrogenesis of human mesenchymal stem cells in fibrin constructs evaluated in vitro and in nude mouse and rabbit defects models10.1016/j.biomaterials.2010.11.003 ↗
21. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute10.1089/ten.tea.2009.0773 ↗
22. Cartilage tissue engineering: directed differentiation of embryonic stem cells in three-dimensional hydrogel culture10.1007/978-1-59745-536-7_24 ↗
23. Chondrogenic differentiation of human mesenchymal stem cells in three-dimensional alginate gels10.1089/tea.2007.0272 ↗
24. Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels10.1115/1.429656 ↗
25. Characterization of proteoglycan production and processing by chondrocytes and BMSCs in tissue engineered constructs10.1016/j.joca.2008.01.004 ↗
26. Matrix-mixed culture: new methodology for chondrocyte culture and preparation of cartilage transplants10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.0.CO;2-9 ↗
27. Interactions between integrin ligand density and cytoskeletal integrity regulate BMSC chondrogenesis10.1002/jcp.21484 ↗
28. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality10.1634/stemcells.20-6-530 ↗
29. Oscillatory tension differentially modulates matrix metabolism and cytoskeletal organization in chondrocytes and fibrochondrocytes10.1016/j.jbiomech.2004.02.048 ↗
30. Does tranexamic acid stabilised fibrin support the osteogenic differentiation of human periosteum derived cells?10.22203/eCM.v021a21 ↗
31. Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels10.1007/s10237-006-0033-2 ↗
32. Fluorometric assay of DNA in cartilage explants using Hoechst 3325810.1016/0003-2697(88)90532-5 ↗
33. Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue10.1006/abio.1996.0502 ↗
34. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction10.1016/0003-2697(87)90021-2 ↗
35. Comprehensive algorithm for quantitative real-time polymerase chain reaction10.1089/cmb.2005.12.1047 ↗
36. Identification and characterization of ligands for L-selectin in the kidney. I. Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin10.1093/intimm/11.3.393 ↗
37. Versican gene expression in human articular cartilage and comparison of mRNA splicing variation with aggrecan10.1042/bj2910361 ↗
38. Gehron Robey P. The biochemistry of bone. Endocrinol Metab Clin North Am 1989;18:858–902.
39. Long-term stable fibrin gels for cartilage engineering10.1016/j.biomaterials.2006.08.027 ↗
40. The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly–Pro–Arg–Pro10.1073/pnas.94.14.7176 ↗
41. Interpenetrating fibrin-alginate matrices for in vitro ovarian follicle development10.1016/j.biomaterials.2009.06.054 ↗
42. Fibrin: a versatile scaffold for tissue engineering applications10.1089/ten.teb.2007.0435 ↗
43. Chondrogenesis of mesenchymal stem cells in gel-like biomaterials in vitro and in vivo10.2741/3020 ↗
44. Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering10.1089/ten.tea.2008.0400 ↗
45. Genipin cross-linked fibrin hydrogels for in vitro human articular cartilage tissue-engineered regeneration10.1159/000209230 ↗
46. Genipin-crosslinked fibrin hydrogels as a potential adhesive to augment intervertebral disc annulus repair10.22203/eCM.v021a28 ↗
47. Bioengineering of dental stem cells in a PEGylated fibrin gel10.2217/rme.11.3 ↗
48. Stabilized autologous fibrin-chondrocyte constructs for cartilage repair in vivo10.1097/01.sap.0000067726.32731.E1 ↗
49. Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels10.1021/bc060265o ↗
50. Injectable tissue-engineered cartilage using a fibrin glue polymer10.1097/00006534-199906000-00001 ↗
51. A biomechanical analysis of an engineered cell-scaffold implant for cartilage repair10.1097/00000637-200105000-00013 ↗
52. Adhesion of tissue-engineered cartilate to native cartilage
53. Injectable tissue-engineered cartilage with different chondrocyte sources10.1097/01.PRS.0000111594.52661.29 ↗
54. Arg–Gly–Asp: a versatile cell recognition signal10.1016/0092-8674(86)90259-X ↗
55. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels10.1016/j.biomaterials.2006.10.006 ↗
56. The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells10.1016/j.biomaterials.2009.09.021 ↗